Palliative radiotherapy for non-small-cell lung cancer: Which dose?

Clinical Oncology

Volumn 17, Issue 1, 2005, Pages 59-60

  Hoskin, Peter J ^a  

^a MOUNT VERNON CANCER CENTRE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGRESSION; CANCER SURVIVAL; DOSIMETRY; EDITORIAL; HUMAN; LIFE EXPECTANCY; LUNG NON SMALL CELL CANCER; PALLIATIVE THERAPY; PRIORITY JOURNAL; RADIATION DOSE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

CARCINOMA, NON-SMALL-CELL LUNG; DOSE FRACTIONATION; DOSE-RESPONSE RELATIONSHIP, RADIATION; HEALTH STATUS; HUMANS; LUNG NEOPLASMS; PALLIATIVE CARE; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS;

EID: 11844299106     PISSN: 09366555     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clon.2004.10.004     Document Type: Editorial

References (11)

1. M. Saunders S. Dische A. Barrett A. Harvey G. Griffiths M. Parmar Continuous, hyperfractionated, accelerated radiotherapy (CHART) vs. conventional radiotherapy in non-small cell lung cancer: Mature data from the randomised multicentre trial. CHART Steering committee Radiother Oncol 52 1999 137-148
2. R.W. Byhardt C. Scott W.T. Sause et al. Response, toxicity, failure patterns, and survival in five radiation therapy oncology group (RTOG) trials of sequential and/or concurrent chemotherapy and radiotherapy for locally advanced non-small-cell carcinoma of the lung Int J Radiat Oncol Biol Phys 42 1998 469-478
3. Medical Research Council Lung Cancer Working Party Inoperable non-small-cell lung cancer (NSCLC): A Medical Research Council randomised trial of palliative radiotherapy with two fractions or ten fractions Br J Cancer 63 1991 265-270
4. Medical Research Council Lung Cancer Working Party A Medical Research Council randomised trial of palliative radiotherapy with two fractions or a single fraction in patients with inoperable non-small-cell lung cancer (NSCLC) and poor performance status Br J Cancer 65 1992 934-941
5. M. Dahele Contemporary non-small-cell lung cancer practice in the United Kingdom Clin Oncol 16 2004 379-380
6. S.C. Erridge M.N. Gaze A. et al. Price Symptom control and quality of life in patients with lung cancer: A randomised trial of two palliative radiotherapy fractionation schedules Clin Oncol 17 2005 61-67
7. F.R. Macbeth J.J. Bolger P. Hopwood et al. Randomized trial of palliative two fraction versus more intensive 13 fraction radiotherapy for patients with inoperable non-small-cell lung cancer and good performance status Clin Oncol 8 1996 167-175
8. A.P. Bezjak M. Dixon M. Brundage et al. Randomized phase III trial of single versus fractionated thoracic radiation in the palliation of patients with lung cancer (NCIC CTG SC.15) Int J Radiat Oncol Biol Phys 54 2002 719-728
9. G.W.P.M. Kramer S.L. Wanders E.M. Noordjik et al. Randomized Dutch National Study of the effect of irradiation with different treatment schemes in the palliation of non-small-cell lung cancer (NSCLC) Lung Cancer 41 suppl 2 2003 S38
10. S. Sundstrom R. Bremnes U. Aasebo et al. Hypofractionated palliative radiotherapy (17 Gy in two fractions) in advanced non-small cell lung carcinoma is comparable to standard fractionation for symptom control and survival: A national phase III trial J Clin Oncol 22 2004 801-810
11. S.J. Falk D.J. Girling R.J. et al. White on behalf of the Medical Research Council Lung Cancer Working Party Immediate versus delayed palliative thoracic radiotherapy in patients with unresectable locally advanced non-small cell lung cancer and minimal thoracic symptoms: randomised controlled trial BMJ 365 2002 465-470